Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-07-12
1999-08-10
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514561, 548535, 558432, 560 38, 560 48, 560122, 560125, 560153, 560168, 560170, 560171, 562443, 562457, 562504, 562507, 564164, 564189, A61K 3140
Patent
active
059359889
ABSTRACT:
The present invention relates to mixtures of .alpha.-amino acids and/or derivatives thereof and cyclopentane-.beta.-amino acids and/or derivatives thereof, dipeptides of the abovementioned .alpha.-amino acids and cyclopentane-.beta.-amino acids and mixtures of the abovementioned mixtures and dipeptides which have an improved tolerability in warm-blooded animals compared with the pure cyclopentane-.beta.-amino acids.
REFERENCES:
patent: 5037809 (1991-08-01), Miyauchi
patent: 5631291 (1997-05-01), Mittendorf
Derwent Abstract of JP 2-174-753, Agricultural Chemistry, p. 4, Derwent Week 9033 (1990).
H. Ohki, et al. J. Antibiot. vol. 44, No. 5, pp. 546-549 (1991).
Kunisch Franz
Matzke Michael
Militzer Hans-Christian
Mittendorf Joachim
Schmidt Axel
Bayer Aktiengesellschaft
Shippen Michael L.
LandOfFree
Tolerability of pharmaceutically active .beta.-amino acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tolerability of pharmaceutically active .beta.-amino acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tolerability of pharmaceutically active .beta.-amino acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1120617